Differences in Outcomes, Factors Associated With Mortality Among Patients With, Without Cancer and SARS-CoV-2

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MAY 9, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.10880?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=050922

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: The results of this systematic review and meta-analysis of 81 studies suggest that patients with cancer and SARSCoV-2 infection had a higher risk of death than patients without cancer. Younger age, lung and hematologic cancer were also risk factors associated with poor outcomes from COVID-19.

Authors: Carlo Palmieri, B.Sc., M.B.B.S., Ph.D., of the University of Liverpool in Liverpool, United Kingdom, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.10880)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.